Danaher (NYSE:DHR) issued its quarterly earnings data on Thursday. The conglomerate reported $1.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.03, MarketWatch Earnings reports. The firm had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.67%. Danaher’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the firm posted $1.00 EPS.

DHR stock opened at $100.39 on Friday. Danaher has a 52 week low of $90.05 and a 52 week high of $110.13. The stock has a market cap of $70.84 billion, a price-to-earnings ratio of 24.91, a P/E/G ratio of 1.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.07 and a current ratio of 1.50.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.64%. Danaher’s dividend payout ratio (DPR) is 15.88%.

In other Danaher news, EVP William K. Daniel sold 103,086 shares of the business’s stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the sale, the executive vice president now directly owns 167,080 shares in the company, valued at approximately $16,813,260.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the business’s stock in a transaction that occurred on Tuesday, July 31st. The stock was sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the completion of the sale, the insider now owns 276,438 shares in the company, valued at $28,163,503.44. The disclosure for this sale can be found here. Insiders have sold a total of 299,961 shares of company stock worth $30,619,691 over the last 90 days. 11.90% of the stock is owned by insiders.

DHR has been the topic of several recent research reports. ValuEngine upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research report on Wednesday, September 19th. Morgan Stanley boosted their price target on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, July 20th. Royal Bank of Canada boosted their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Robert W. Baird dropped their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $112.14.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Article: How Short Selling Works

Earnings History for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.